Trial
NCT01227408
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
CTI BioPharma
Condition
Breast Cancer
Intervention
doxorubicin, paclitaxel poliglumex, capecitabine, cyclophosphamide, methotrexate
Why stopped
Sponsor withdrew due to funding issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-02